![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
https://orcid.org/0000-0002-1915-1031
References
- Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. 2015. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology 45:16–26.
- Alfirevic Z, Navaratnam K, Mujezinovic F. 2017. Amniocentesis and chorionic villus sampling for prenatal diagnosis. The Cochrane Database of Systematic Reviews 4:CD003252.
- Bakker M, Birnie E, Medina RD, Sollie KM, Pajkrt E, Bilardo CM. 2017. Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study. Ultrasound in Obstetrics and Gynecology 49:599–606.
- Beta J, Zhang W, Geris S, Kostiv V, Akolekar R. 2019. Procedure related risk of miscarriage from chorionic villus sampling and amniocentesis. Ultrasound in Obstetrics and Gynaecology.
- Bilardo CM, Müller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK. 2007. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound in Obstetrics and Gynecology 30:11–18.
- Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, et al. 2006. Pregnancy loss rates after midtrimester amniocentesis. Obstetrics and Gynaecology 108:1067–1072.
- Hsu WW, Hsieh CJ, Lee CN, Chen CL, Lin MW, Kang J, et al. 2019. Complication rates after chorionic villus sampling and mid-trimester amniocentesis: a 7-year national registry study. Journal of Formosan Medical Association.
- Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH. 2003. Megacystis at 10–14 weeks of gestation: chromosomal defects and outcome according to bladder length. Ultrasound in Obstetrics and Gynecology 21:338–341.
- Mujezinovic F, Alfirevic Z. 2007. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstetrics and Gynecology 110:687–694.
- Odibo AO, Dicke JM, Gray DL, Oberle B, Stamilio DM, Macones GA, Crane JP. 2008b. Evaluating the rate and risk factors for fetal loss after chorionic villus sampling. Obstetrics and Gynecology 112:813–819.
- Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP. 2008a. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstetrics and Gynecology 111:589–595.
- RCOG. 2010. Amniocentesis and chorionic villus sampling. Royal College of Obstetricians and Gynaecologists. Green top guideline no. 8. London: RCOG; [cited 2020 Feb 15]. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_8.pdf
- Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. 1986. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1:1287–1293.
- Tabor A, Vestergaard CH, Lidegaard Ø. 2009. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound in Obstetrics and Gynecology 34:19–24.
- Tanriverdi HA, Ertan AK, Hendrik HJ, Remberger K, Schmidt W. 2005. Outcome of cystic hygroma in fetuses with normal karyotypes depends on associated findings. European Journal of Obstetrics, Gynecology, and Reproductive Biology 118:40–46.
- Wulff CB, Gerds TA, Rode L, Ekelund CK, Petersen OB, Tabor A. 2016. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies. Ultrasound in Obstetrics and Gynecology 47:38–44.